Literature DB >> 1949959

Erythromycin-felodipine interaction.

H Liedholm, G Nordin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1949959     DOI： 10.1177/106002809102500918

Source DB:  PubMed          Journal:  DICP        ISSN： 1042-9611


× No keyword cloud information.
  10 in total

Review 1.  Calcium antagonists. Drug interactions of clinical significance.

Authors:  T Rosenthal; D Ezra
Journal:  Drug Saf       Date:  1995-09       Impact factor: 5.606

Review 2.  Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition.

Authors:  G K Dresser; J D Spence; D G Bailey
Journal:  Clin Pharmacokinet       Date:  2000-01       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of fibric acid derivatives (fibrates).

Authors:  D B Miller; J D Spence
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

4.  The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers.

Authors:  Alissa J Wright; Tara Gomes; Muhammad M Mamdani; John R Horn; David N Juurlink
Journal:  CMAJ       Date:  2011-01-17       Impact factor: 8.262

Review 5.  Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1992-08       Impact factor: 9.546

Review 6.  Macrolide antibacterials. Drug interactions of clinical significance.

Authors:  N A von Rosensteil; D Adam
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

Review 7.  Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in older patients.

Authors:  D Faulds; E M Sorkin
Journal:  Drugs Aging       Date:  1992 Sep-Oct       Impact factor: 3.923

8.  Drug-drug interactions and acute kidney injury: caveat prescriptor.

Authors:  Mallika L Mendu; Sushrut S Waikar
Journal:  Am J Kidney Dis       Date:  2014-05-10       Impact factor: 8.860

Review 9.  Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.

Authors:  F Pea; M Furlanut
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 5.577

10.  A Physiologically Based Pharmacokinetic and Pharmacodynamic Model of the CYP3A4 Substrate Felodipine for Drug-Drug Interaction Modeling.

Authors:  Laura Maria Fuhr; Fatima Zahra Marok; Maximilian Mees; Felix Mahfoud; Dominik Selzer; Thorsten Lehr
Journal:  Pharmaceutics       Date:  2022-07-15       Impact factor: 6.525
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.